Evaluations

in page functions

28 June 2011

IFFIm evaluation: GAVI Secretariat response

GAVI Secretariat response to IFFIm evaluation which assessed both IFFIm’s efficacy as a financing mechanism, as well as the extent to which IFFIm has contributed to enhancing GAVI’s impact on immunisation and health.

  • Author(s):
  • HLSP
  • Total pages:
  • 5

21 June 2011

IFFIm evaluation: full report

The IFFIm evaluation assesses the extent to which IFFIm is an effective and efficient instrument to attract long-term, predictable donor funds and to frontload money to finance GAVI Alliance support for immunisation and health systems.

  • Author(s):
  • HLSP
  • Total pages:
  • 175

20 April 2011

IFFIm evaluation: annexes

1 . A. 21 February 2011 Evaluation of the International Finance Facility for Immunisation (IFFIm) ANNEXES April 2011 HLSP, Sea Containers House, 20 Upper Ground, London SE1 9LZ, United Kingdom T +44 (0)20 7803 4545 F +44 (0)20 7803 4502, W www.hlsp.org Evaluation of the International Finance Facility for Immunisation (

  • Author(s):
  • HLSP
  • Total pages:
  • 155

03 February 2011

Second GAVI Evaluation 2006-2010

This evaluation seeks to answer two high-level questions: to what extent has the GAVI Alliance met its four Strategic Goals (SGs); and to what extent has the GAVI Alliance added value at the global and country levels, over and above what would have been accomplished without the Alliance?

  • Author(s):
  • CEPA LLP1 in association with Applied Strategies2 and Ulla Griffiths (Lecturer in Health Economics, London School of Hygiene and Tropical Medicine)
  • Review date:
  • 10 December 2010
  • Total pages:
  • 152
  • Publisher:
  • GAVI

29 October 2010

Baseline Study for pneumococcal vaccine AMC

The goal of the AMC baseline study was to establish the environment prior to the AMC with baseline estimates for a selection of indicators related to the objectives of the AMC and to model counterfactual scenarios to ascertain the potential impact of the AMC vis-a-vis traditional financial and procurement strategies.

  • Author(s):
  • Swiss Centre for International Health (SCIH)
  • Total pages:
  • 177

01 October 2010

Evaluation Advisory Committee report to the Board on the Second GAVI Evaluation

The Committee's overall assessment is that this is a credible and useful evaluation. The evaluation has yielded a number of important insights that will prove useful to the Board and Alliance as it prepares for and then implements its new strategy for the 2011-15 period.

  • Author(s):
  • GAVI Alliance Board Evaluation Advisory Committee
  • Total pages:
  • 3

13 September 2010

Supporting Paper 5: Progress against recommendations made by the Phase I Evaluation

Table presenting the key recommendations made by the Phase 1 evaluation and the GAVI Secretariat response. In addition, CEPA has interviewed Secretariat colleagues to understand progress made to date against these recommendations, which is noted in the final column labelled ‘implementation progress’.

  • Author(s):
  • Cambridge Economic Policy Associates (CEPA) for GAVI Alliance
  • Total pages:
  • 14

13 September 2010

Supporting Paper 4.1: Bangladesh country study report

The report provides contextual information on Bangladesh’s health and immunisation sector, and assesses the results and value add of GAVI programs in the country from the country stakeholders’ perspective.

  • Author(s):
  • Cambridge Economic Policy Associates (CEPA) for GAVI Alliance
  • Total pages:
  • 66

13 September 2010

Supporting Paper 10.3: SG4 report annexes

Supporting paper 10.3 of the second GAVI evaluation.

  • Author(s):
  • Cambridge Economic Policy Associates (CEPA) for GAVI Alliance
  • Total pages:
  • 37

13 September 2010

Supporting Paper 1: Bibliography

Bibliography to the second GAVI evaluation.

  • Author(s):
  • Cambridge Economic Policy Associates (CEPA) for GAVI Alliance
  • Total pages:
  • 19

Searching... One moment please

 



close icon

modal window here